Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer (NCT02926690) | OncoTherapy Science, Inc. | 2017-05-29 |
Track Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.